SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Ciena (CIEN) -- Ignore unavailable to you. Want to Upgrade?


To: jach who wrote (3206)9/16/1998 6:00:00 PM
From: Candle stick  Read Replies (1) | Respond to of 12623
 
Read the story about Ciena's charges LU sabotaged merger here:
(scroll to the bottom.)
cbs.marketwatch.com

Ciena Corp. (CIEN) said it believes an unnamed competitor may have
sabotaged its merger with Tellabs (TLAB), the Washington Post reported.
Ciena said it traced some evidence to an e-mail at Lucent Technologies
(LU). See press briefing. The news comes after the Tellabs cancelled the
merger on Monday. Ciena fell 5/8 to 12 3/8. Tellabs climbed 2 3/8 to 43
5/8.

and this:

Compiled by CBS MarketWatch
Last Update: 7:45 AM ET Sep 16, 1998

WASHINGTON (CBS.MW) -- Ciena Corp. (CIEN) said it believes an
unnamed competitor may have sabotaged its merger with Tellabs Inc.
(TLAB), The Washington Post reported Wednesday, citing a Ciena filing
with the Securities and Exchange Commission. Ciena said it had traced
some evidence to an email at Lucent Technologies Inc. (LU). Ciena also
accused Wall Street traders of planting damaging news about Ciena to
drive down its stock price. Ciena didn't ask the SEC to take any action.
Ciena's deal with Tellabs collapsed on Monday. (The Washington Post)




To: jach who wrote (3206)9/16/1998 6:09:00 PM
From: professor  Read Replies (3) | Respond to of 12623
 
The news today tells you again the desire of Lucent to squash the deal between Cienna and Tellabs. Tellabs wasn't smart enough to realize what was happening and got duped by Lucent. Isn't the outcome exactly what you would have wanted if you were Lucent. Ruin your competitor by putting out false information about their product and letting short sellers feed on this information. Coupled with stock weakness TLAB started to think their pristine stock price was linked to the deal. If TLAB had talked up the deal all the way through and not wavered, the deal would have gotten done, TLAB stock price would be over $60 and CIEN's name wouldn't have been ruined in the eyes of their customers. This is EXACTLY what Lucent hoped would happen and it did. Both Ciena and Tellabs have ruined their own future. They should have done the deal without haggling over price. Questioning the underlying business of a company you are about to buy will only undermine that company's business and possibly your future. Although some say TLAB Mikce Birke is smart I think he got bad advice on how the stock market and shareholders perceive things. He should have stuck to his guns about the long term vision of selling Ciena products within the Tellabs framework. The shareholders that were complaining about the deal were short term momentum players not long term holders who understood the future prospects of the company without Ciena. When the deal was called off the long term holders sold heavily despite some small buying from arbs and short term momentum players. TLAB stock price will not appreciate without the underlying support of long term holders. So Birke didn't really understand the workings of Wall Street and fell right into the grand strategy of Lucent. Lucent knows how to run their business and how to work Wall Street to its advantage. This is evidence by their ability to get a 50 multiple on 1999 numbers and be considered pristine. TLAB has lost that status and can't get it back for a long, long time.



To: jach who wrote (3206)9/16/1998 6:33:00 PM
From: gbh  Respond to of 12623
 
FYI, this news came out this morning. This news, and a quarter will get you a cup of coffee.

Its more likely that Nettles sabotaged this merger by overpricing his company, and refusing to accept a price reflective of its market value.